Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. annual/quarterly cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Protalix Biotherapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 14.7M, a 25.71% decrease year-over-year.
- Protalix Biotherapeutics Inc. cash on hand for 2025 were 14.7M, a 25.71% decrease from 2024.
- Protalix Biotherapeutics Inc. cash on hand for 2024 were 19.8M, a 16.39% decrease from 2023.
- Protalix Biotherapeutics Inc. cash on hand for 2023 were 23.6M, a 38.12% increase from 2022.
- Protalix Biotherapeutics Inc. cash on hand for 2022 were 17.1M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Protalix Biotherapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $15 |
| 2024 | $20 |
| 2023 | $24 |
| 2022 | $17 |
| 2021 | $39 |
| 2020 | $18 |
| 2019 | $18 |
| 2018 | $38 |
| 2017 | $51 |
| 2016 | $63 |
| 2015 | $76 |
| 2014 | $55 |
| 2013 | $86 |
| 2012 | $52 |
| 2011 | $27 |
| Protalix Biotherapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $15 |
| 2024-12-31 | $20 |
| 2023-12-31 | $24 |
| 2022-12-31 | $17 |
| 2021-12-31 | $39 |
| 2020-12-31 | $18 |
| 2019-12-31 | $18 |
| 2018-12-31 | $38 |
| 2017-12-31 | $51 |
| 2016-12-31 | $63 |
| 2015-12-31 | $76 |
| 2014-12-31 | $55 |
| 2013-12-31 | $86 |
| 2012-12-31 | $52 |
| 2011-12-31 | $27 |
| 2010-12-31 | $36 |
Protalix Biotherapeutics Inc. Cash on Hand — FAQ
Protalix Biotherapeutics Inc. (PLX) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLX's cash on hand history?
The chart and table above show Protalix Biotherapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.